Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Drugs
781 - 800 of 1,297 Results
-
-
FDA Overlooked Red Flags In Drugmaker鈥檚 Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial
As states struggle to respond to the national drug crisis, officials around the country are watching Oklahoma. The state's attorney general says opioid drugmakers helped ignite a health crisis that has killed thousands of residents.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Why Missouri’s The Last Holdout On A Statewide Rx Monitoring Program
For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.
By Lauren Weber -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 鈥楥onscience鈥 Rules, Rx Prices and Still More Medicare
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss the latest news about the Trump administration鈥檚 effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
-
Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads 鈥 just like side effects.
By Julie Appleby and Sydney Lupkin -
Addiction Medicine Mostly Prescribed To Whites, Even As Opioid Deaths Rose Among Blacks
A study looked at who gets Suboxone prescriptions and found that whites are almost 35 times more likely to get the addiction treatment than African Americans.
-
The Money And Politics Of Prescription Drugs: What You Need To Know
America spends about as much on prescription drugs as all the revenues of the three big car makers combined. Tracking where the money goes is hard. PolitiFact has some charts to help.
-
Drug Industry Patents Go Under Senate Judiciary Committee鈥檚 Microscope
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
By Rachel Bluth -
CBO鈥檚 Report On Single-Payer Health Care Holds More Questions Than Answers
The Congressional Budget Office report does clearly communicate that shifting to this type of health system would be a complicated process.
-
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris鈥 claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Newsom: California Leads On Prescription Drugs
California Gov. Gavin Newsom claims that his state is 鈥渓eading the nation in holding drug companies accountable and fighting prescription drug prices.鈥 Is that really the case?
-
Klobuchar Wants To Stop 鈥楶ay-For-Delay鈥 Deals That Keep Drug Prices High
It鈥檚 as shady as it sounds.
-
Pain Clinics’ Doctors Needlessly Tested Hundreds Of Urine Samples, Court Records Show
Whistleblower lawsuits accuse Tennessee chain of bilking millions from Medicare for unnecessary urine drug tests.
By Fred Schulte